Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
August 10, 2020 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2020 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 15, 2020 CT ORDER

CT ORDER

View HTML
July 2, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
July 2, 2020 3

Initial filing by director officer or owner of more than ten percent.

View HTML
June 18, 2020 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 12, 2020 CT ORDER

CT ORDER

View HTML
June 9, 2020 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 9, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
June 9, 2020 4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us